Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-06-21 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于深圳证券交易所创业板非许可类重组问询函【2021】第6号回复的公告
Audit Report / Information Classification · 95% confidence The document is a detailed announcement and response regarding a non-permitted type restructuring inquiry letter from the Shenzhen Stock Exchange's ChiNext board. It discusses a major asset purchase and related transaction report draft, focusing on the acquisition and operational details of Suzhou Guangci Tumor Hospital. The content includes extensive disclosures about cooperation agreements, operational independence, medical staff, equipment, hospital grading, and valuation of the target asset. The document is lengthy (15,000 characters) and contains substantive business and financial information related to a major asset purchase and restructuring transaction. It is not a full annual or interim financial report, nor is it a simple announcement or certification. The focus on a major asset purchase and related restructuring inquiry aligns with the category of Audit Report / Information (AR), which includes standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. The document is not a merger proxy statement or tender offer, so it is not MA or TAR. It is not a call transcript, earnings release, or other categories. Therefore, the best fit is AR (Audit Report / Information). FY 2020
2021-06-21 Chinese
国泰君安证券股份有限公司关于公司关于深圳证券交易所《关于对盈康生命科技股份有限公司的重组问询函》回复之核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion and response to an inquiry letter from the Shenzhen Stock Exchange regarding a major asset purchase and related party transaction by Yingkang Life Technology Co., Ltd. It includes extensive financial data, legal opinions, compliance with accounting standards, impact on ongoing operations, and detailed disclosures about litigation, asset impairment, and administrative penalties. The content is consistent with a comprehensive report related to a major asset restructuring transaction, including audit and legal review aspects. This type of document is typically part of a Major Asset Restructuring Report or a standalone Audit Report / Information document related to a specific transaction, but it is not a full Annual Report or Interim Report. It is not a brief announcement or a presentation but a detailed verification and opinion report. Therefore, the most appropriate classification is Audit Report / Information (AR). FY 2020
2021-06-21 Chinese
国泰君安证券股份有限公司关于公司重大资产购买暨关联交易之独立财务顾问报告（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" related to a "Major Asset Purchase and Related Party Transaction" involving a listed company. It contains detailed sections including transaction overview, asset evaluation, compliance analysis, and legal opinions. The content includes extensive financial data, transaction details, and regulatory references, indicating it is a comprehensive advisory report on a significant asset acquisition and related party transaction. This type of document is typically classified as a Capital/Financing Update (CAP) because it provides detailed information on a major financing or capital transaction rather than a full annual or interim report, audit report, or other categories. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is CAP with high confidence.
2021-06-21 Chinese
重大资产购买暨关联交易报告书（草案）（修订稿）摘要
Capital/Financing Update Classification · 95% confidence The document is titled as a "重大资产购买暨关联交易报告书（草案）（修订稿）摘要" which translates to "Major Asset Purchase and Related Party Transaction Report (Draft) (Revised) Summary." It details a significant asset purchase transaction by 盈康生命科技股份有限公司, including transaction parties, asset valuation, financial impacts, approvals, and related legal and financial advisory statements. The document includes detailed financial data, transaction structure, and compliance with regulatory requirements for a major asset purchase and related party transaction. It is not a full annual or quarterly report, nor an earnings release or a simple announcement. It is a comprehensive report on a major asset purchase and related party transaction, which fits the category of a Capital/Financing Update (CAP) as it involves significant financing and capital structure changes through asset acquisition. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement or summary. Therefore, the appropriate classification is CAP with high confidence.
2021-06-21 Chinese
信永中和会计师事务所(特殊普通合伙)关于《关于对盈康生命科技股份有限公司的重组问询函》（创业板非许可类重组问询函〔2021〕第 6 号）的回复
Audit Report / Information Classification · 95% confidence The document is a detailed response from an accounting firm (信永中和会计师事务所) to an inquiry letter regarding a company's restructuring (盈康生命科技股份有限公司). It includes extensive accounting and audit-related explanations, verification of asset impairment, medical dispute liabilities, and compliance with accounting standards. The document is not a full annual or interim report but rather a standalone audit-related response to regulatory inquiries about accounting treatments and asset valuations. It contains audit procedures and conclusions but does not present comprehensive financial statements or management discussion typical of annual or interim reports. Therefore, it fits the category of an Audit Report / Information (AR). The document length (6894 characters) and content support this classification with high confidence. FY 2020
2021-06-21 Chinese
关于重大资产购买暨关联交易报告书（草案）修订说明的公告
Capital/Financing Update Classification · 90% confidence The document is an announcement regarding revisions to a draft report on a major asset purchase and related party transaction by 盈康生命科技股份有限公司. It references board meetings, regulatory inquiries, and detailed disclosures about the transaction and related financial and operational information of the target company. The document is relatively short (2187 characters) and primarily serves to inform about amendments to a transaction report draft rather than presenting full financial statements or comprehensive analysis. It does not contain full financial data or constitute a full report like an Annual Report or Interim Report. Instead, it is an announcement about the revision of a transaction report draft, which aligns with the category of Capital/Financing Update (CAP) as it relates to a significant asset purchase and related party transaction disclosures.
2021-06-21 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.